Iron Deficiency Injectable Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

What industry-specific factors are fueling the growth of the iron deficiency injectable market?
The rise in polycystic cases is predicted to stimulate the expansion of the iron deficiency injectables market. PCOS is a prevalent hormonal dysfunction occurring mostly in women of childbearing age who have ovaries. PCOS causes an excess of iron, leading to excessive menstrual bleeding and subsequently causing anemia in patients. This condition can be treated using injectable iron deficiency drugs. As per the World Health Organization in June 2023, globally, PCOS affects around 8-13% of women of reproductive age, out of which about 70% go undiagnosed. Hence, the increasing occurrence of PCOS is triggering the growth of iron deficiency injectables market. Iron Deficiency Injectable Market Driver: Increase in Malnutrition Incidences Fuels Growth In The Iron Deficiency Injectable Market

Get Your Iron Deficiency Injectable Market Report Here:
https://www.thebusinessresearchcompany.com/report/iron-deficiency-injectable-global-market-report

What Is the projected market size and growth rate for the iron deficiency injectable market?
The market for iron deficiency injectables has seen robust growth lately. Predictions state that the market would expand from $14.06 billion in 2024 to $15.37 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. This historical growth trend is linked to the increasing number of treatments for iron deficiency anemia, bariatric surgery patients, pediatric and adolescent patients, along with the increase in pregnancy rates.

The market for injectable treatments for iron deficiency is projected to witness accelerated expansion in the upcoming years, with an estimate to reach $23.13 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.8%. The anticipated increase over the forecast period can be credited to such factors as increasing geriatric population, worldwide health initiatives, governmental support, heightened treatments for chronic conditions, and quick replenishment of iron. The period is likely to experience notable trends such as developments in iron formulations, expansion of digital health solutions, advances in therapy for iron deficiency through injections, and wider acceptance of iron-centric medications.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12907&type=smp

What new trends are reshaping the iron deficiency injectable market and its opportunities?
Leading companies in the iron deficiency injectables market, such as INJECTAFER, are innovating new therapies to maintain their dominance. For example, in June 2023, Daiichi Sankyo Company, a US healthcare firm, and American Regent Inc., a US injectables producer, introduced INJECTAFER (ferric carboxymaltose injection) for iron deficiency, which received approval from the Food And Drug Administration, a US government entity. This is the inaugural and sole intravenous iron replacement therapy for adult patients coping with advancing heart failure that has gained FDA approval. With INJECTAFER, over 40 clinical trials involving more than 8,800 participants from various nations have been conducted. This latest authorization expands on the proven and successful application of INJECTAFER in these patients, encompassing both adults and children suffering from iron-deficient anemia and heart failure.

What major market segments define the scope and growth of the iron deficiency injectable market?
The iron deficiency injectable market covered in this report is segmented -

1) By Type: Iron Dextran, Iron Sucrose, Ferric Carboxymaltose
2) By Branded or Generics: Branded, Generics
3) By Application: Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Other Applications
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Iron Dextran: Low Molecular Weight Iron Dextran, High Molecular Weight Iron Dextran
2) By Iron Sucrose: Venofer
3) By Ferric Carboxymaltose: Injectafer, Ferinject

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12907

Which region dominates the iron deficiency injectable market?
North America was the largest region in the iron deficiency injectable market in 2024. The regions covered in iron deficiency injectable market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which key market leaders are driving the iron deficiency injectable industry growth?
Major companies operating in the iron deficiency injectable market are Daiichi Sankyo Company Limited, Pfizer Inc., Aetna Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, AstraZeneca PLC, GSK PLC, Fresenius Medical Care, Teva Pharmaceutical Industries Ltd., Mylan N.V., B Braun Medical Inc., Sandoz, Fresenius Kabi AG, Cipla Limited, Emcure Pharmaceuticals Ltd., AMAG Pharmaceuticals Inc., Luitpold Pharmaceuticals Inc., Akebia Therapeutics Inc., Covis Pharma GmbH, Keryx Biopharmaceuticals Inc., Rockwell Medical Inc., American Regent Inc., Galen Medical Group.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=12907&type=smp

What Is Covered In The Iron Deficiency Injectable Global Market Report?

•Market Size Forecast: Examine the iron deficiency injectable market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the iron deficiency injectable market for a structured understanding.
•Key Players Overview: Analyze major players in the iron deficiency injectable market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the iron deficiency injectable market.
•Segment Contributions: Evaluate how different segments drive overall growth in the iron deficiency injectable market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the iron deficiency injectable market.
•Industry Challenges: Identify potential risks and obstacles affecting the iron deficiency injectable market.
•Competitive Landscape: Review strategic developments in the iron deficiency injectable market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.